Lung cancer trials in Czechia
34 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 12 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleEffect of Trilaciclib in the Prevention of Myelosupression in Subjects With Limited-stage Small Cell Lung Cancer
- Where
- Ostrava
- Age
- 18 years and over
- People
- 120 worldwide
- Run by
- Pharmacosmos A/S
See details and how to joinNCT07473128 · EU 2025-525026-35-00 - Phase 3Taking peopleNeladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
- Where
- Nový Jičín, Pardubice
- Age
- 18 years and over
- People
- 450 worldwide
- Run by
- Nuvalent Inc.
See details and how to joinNCT06765109 · EU 2024-517553-26-00 - Phase 3Taking peopleThis is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
- Where
- Liberec I-Stare Mesto, Nový Jičín, Olomouc, Prague, Prague 4
- Age
- 18 years and over
- People
- 714 worldwide
- Run by
- Pfizer
See details and how to joinNCT06758401 · EU 2024-517968-36-00 - Phase 3Taking peopleRoll Over StudY for Patients Who Have Completed a Previous Oncology Study with Durvalumab
- Where
- Olomouc
- Age
- 18 years and over
- People
- 87 worldwide
- Run by
- Astrazeneca AB
See details and how to joinNCT05303532 · EU 2023-507337-22-00 - Phase 1Taking peopleTrial of the novel peroral anti-tumor treatment in patients with solid tumors
- Where
- Brno-Stred
- Age
- 18 years and over
- People
- 30
- Run by
- VUAB Pharma a.s.
See details and how to join2024-511215-21-00 · EU 2024-511215-21-00 - Phase 1/2Taking peopleStudy of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid Tumors
- Where
- Brno-Stred
- Age
- 18 years to 100 years
- People
- 280 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06726148 · EU 2024-517281-42-00 - Phase 3Taking peopleA Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
- Where
- Liberec I-Stare Mesto, Olomouc, Prague
- Age
- 18 years and over
- People
- 540 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06203210 · EU 2023-509628-16-00 - No phaseTaking peopleConfocal Laser Endomicroscopy VERification
- Where
- Prague
- Age
- 18 years and over
- People
- 208 worldwide
- Run by
- Amsterdam University Medical Centers (UMC), Location Academic Medical Center (AMC)
See details and how to joinNCT06079970 - No phaseTaking peopleStudy of Early Cancer Biomarkers in Breath Condensate in Population of Individuals With High-Risk of Lung Cancer Undergoing LDCT Screening.
- Where
- Brno, Olomouc, Prague
- Age
- 55 years to 74 years
- People
- 3,200
- Run by
- The Institute of Molecular and Translational Medicine, Czech Republic
See details and how to joinNCT06016569